Singapore approves RSV vaccine for people aged from 60

From July 18, Singaporeans aged 60 and above can get vaccinated against a contagious virus that causes respiratory tract infections and could lead to complications in older folk.

The Health Sciences Authority of Singapore (HSA) has certified the vaccine Arexvy protects against lower respiratory tract disease caused by the contagious virus, which poses greater risks to older adults.(Photo: chemxpert.com)

The vaccine Arexvy developed by British pharmaceutical giant GSK protects people against the respiratory syncytial virus (RSV).

The Health Sciences Authority of Singapore (HSA) on May 10 certified the vaccine protects against lower respiratory tract disease caused by the contagious virus, which poses greater risks to older adults.

So far, the vaccine, provided only for Singaporeans aged 60 and above, is available at some general practitioner and specialist clinics at prices of 320-350 SGD (238.5-260.8 USD) per only dose, according to the Straits Times.

According to the HSA, the vaccine is the first for the virus to be available in Singapore, and an application for its use for those between 50 and 59 is still under review./.

VNA

• Green investment strategy expected to boost Malaysian economy (18/07)
• Conflict with Hamas takes toll on Israel's economy (17/07)
• Bad debts in housing hinder Thailand's economic growth​ (17/07)
• Efforts made to promote digital payment integration in ASEAN (16/07)
• KPL praises President To Lam's visit as boost to bilateral ties (15/07)
• Thailand’s consumer confidence slips in June (12/07)
• Indonesia considers easing bauxite export ban (11/07)